Matches in SemOpenAlex for { <https://semopenalex.org/work/W2964189413> ?p ?o ?g. }
- W2964189413 endingPage "2078" @default.
- W2964189413 startingPage "2066" @default.
- W2964189413 abstract "Abstract Background Scarce evidence associates the first-year estimated glomerular filtration rate (eGFR) variability and longitudinal change scales concomitantly to the risk of developing end-stage renal disease (ESRD), acute coronary syndrome (ACS) and death following pre-ESRD program enrollment in chronic kidney disease (CKD). Methods We conducted a prospective cohort study of 5092 CKD patients receiving multidisciplinary care between 2003 and 2015 with careful ascertainment of ESRD, ACS and death during the follow-up. First-year eGFR variability and longitudinal change scales that were based on all first-year eGFR measurements included coefficient of variation of eGFR (eGFR-CV), percent change (eGFR-PC), absolute difference (eGFR-AD), slope (eGFR-slope) and area under the curve (AUC). Results A total of 786 incident ESRD, 292 ACS and 410 death events occurred during the follow-up. In the multiple Cox regression, the fully adjusted hazard ratios (HRs) of progression to ESRD for each unit change in eGFR-CV, eGFR-PC, eGFR-AD, eGFR-slope, eGFR-AUC were 1.03 [95% confidence interval (CI) 1.02–1.04], 1.04 (1.03–1.04), 1.16 (1.14–1.18), 1.16 (1.14–1.17) and 1.04 (1.03–1.04), respectively. The adjusted HRs for incident ESRD comparing the extreme with the reference quartiles of eGFR-CV, eGFR-PC, eGFR-AD, eGFR-slope and eGFR-AUC were 2.67 (95% CI 2.11–3.38), 8.34 (6.33–10.98), 19.08 (11.89–30.62), 13.08 (8.32–20.55) and 6.35 (4.96–8.13), respectively. Similar direction of the effects on the risk of developing ACS and mortality was observed. In the 2 × 2 risk matrices, patients with the highest quartile of eGFR-CV and concomitantly with the most severely declining quartiles of any other longitudinal eGFR change scale had the highest risk of all outcomes. Conclusions The dynamics of eGFR changes, both overall variability and longitudinal changes, over the first year following pre-ESRD program enrollment are crucial prognostic factors for the risk of progression to ESRD, ACS and deaths among patients with CKD. A risk matrix combining the first-year eGFR variability and longitudinal change scales following pre-ESRD enrollment is a novel approach for risk characterization in CKD care. Randomized trials in CKD may be required to ascertain comparable baseline eGFR dynamics." @default.
- W2964189413 created "2019-07-30" @default.
- W2964189413 creator A5032258432 @default.
- W2964189413 creator A5032376286 @default.
- W2964189413 creator A5032750183 @default.
- W2964189413 creator A5037959921 @default.
- W2964189413 creator A5045184717 @default.
- W2964189413 creator A5051818492 @default.
- W2964189413 creator A5063007108 @default.
- W2964189413 creator A5075544102 @default.
- W2964189413 date "2018-07-05" @default.
- W2964189413 modified "2023-09-25" @default.
- W2964189413 title "First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease" @default.
- W2964189413 cites W1492028803 @default.
- W2964189413 cites W1963911865 @default.
- W2964189413 cites W1966238570 @default.
- W2964189413 cites W1968675464 @default.
- W2964189413 cites W1970364947 @default.
- W2964189413 cites W1986359141 @default.
- W2964189413 cites W2038981426 @default.
- W2964189413 cites W2041570990 @default.
- W2964189413 cites W2052396810 @default.
- W2964189413 cites W2067870554 @default.
- W2964189413 cites W2073742622 @default.
- W2964189413 cites W2077967941 @default.
- W2964189413 cites W2114956091 @default.
- W2964189413 cites W2128783545 @default.
- W2964189413 cites W2140155018 @default.
- W2964189413 cites W2155207788 @default.
- W2964189413 cites W2155965977 @default.
- W2964189413 cites W2156579478 @default.
- W2964189413 cites W2157076494 @default.
- W2964189413 cites W2165817472 @default.
- W2964189413 cites W2171951277 @default.
- W2964189413 cites W2262388276 @default.
- W2964189413 cites W2292322589 @default.
- W2964189413 cites W2326160428 @default.
- W2964189413 cites W2402841512 @default.
- W2964189413 cites W2567056004 @default.
- W2964189413 cites W2591419591 @default.
- W2964189413 cites W2767567826 @default.
- W2964189413 cites W4235787011 @default.
- W2964189413 doi "https://doi.org/10.1093/ndt/gfy200" @default.
- W2964189413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29982714" @default.
- W2964189413 hasPublicationYear "2018" @default.
- W2964189413 type Work @default.
- W2964189413 sameAs 2964189413 @default.
- W2964189413 citedByCount "13" @default.
- W2964189413 countsByYear W29641894132018 @default.
- W2964189413 countsByYear W29641894132019 @default.
- W2964189413 countsByYear W29641894132020 @default.
- W2964189413 countsByYear W29641894132021 @default.
- W2964189413 countsByYear W29641894132022 @default.
- W2964189413 countsByYear W29641894132023 @default.
- W2964189413 crossrefType "journal-article" @default.
- W2964189413 hasAuthorship W2964189413A5032258432 @default.
- W2964189413 hasAuthorship W2964189413A5032376286 @default.
- W2964189413 hasAuthorship W2964189413A5032750183 @default.
- W2964189413 hasAuthorship W2964189413A5037959921 @default.
- W2964189413 hasAuthorship W2964189413A5045184717 @default.
- W2964189413 hasAuthorship W2964189413A5051818492 @default.
- W2964189413 hasAuthorship W2964189413A5063007108 @default.
- W2964189413 hasAuthorship W2964189413A5075544102 @default.
- W2964189413 hasConcept C126322002 @default.
- W2964189413 hasConcept C126894567 @default.
- W2964189413 hasConcept C159641895 @default.
- W2964189413 hasConcept C188816634 @default.
- W2964189413 hasConcept C207103383 @default.
- W2964189413 hasConcept C2778653478 @default.
- W2964189413 hasConcept C2779134260 @default.
- W2964189413 hasConcept C3019040382 @default.
- W2964189413 hasConcept C44249647 @default.
- W2964189413 hasConcept C50382708 @default.
- W2964189413 hasConcept C68443243 @default.
- W2964189413 hasConcept C71924100 @default.
- W2964189413 hasConcept C76318530 @default.
- W2964189413 hasConceptScore W2964189413C126322002 @default.
- W2964189413 hasConceptScore W2964189413C126894567 @default.
- W2964189413 hasConceptScore W2964189413C159641895 @default.
- W2964189413 hasConceptScore W2964189413C188816634 @default.
- W2964189413 hasConceptScore W2964189413C207103383 @default.
- W2964189413 hasConceptScore W2964189413C2778653478 @default.
- W2964189413 hasConceptScore W2964189413C2779134260 @default.
- W2964189413 hasConceptScore W2964189413C3019040382 @default.
- W2964189413 hasConceptScore W2964189413C44249647 @default.
- W2964189413 hasConceptScore W2964189413C50382708 @default.
- W2964189413 hasConceptScore W2964189413C68443243 @default.
- W2964189413 hasConceptScore W2964189413C71924100 @default.
- W2964189413 hasConceptScore W2964189413C76318530 @default.
- W2964189413 hasFunder F4320322795 @default.
- W2964189413 hasIssue "12" @default.
- W2964189413 hasLocation W29641894131 @default.
- W2964189413 hasLocation W29641894132 @default.
- W2964189413 hasOpenAccess W2964189413 @default.
- W2964189413 hasPrimaryLocation W29641894131 @default.
- W2964189413 hasRelatedWork W1967581221 @default.
- W2964189413 hasRelatedWork W2014778483 @default.
- W2964189413 hasRelatedWork W2037157324 @default.